Mayzent (siponimod)

pCPA File Number: 21280
Negotiation Status:
Under consideration for negotiation
Indication(s):
Secondary progressive multiple sclerosis (SPMS)
Sponsor/Manufacturer:
NOVARTIS PHARMACEUTICALS CANADA INC
CADTH Project Number:
SR0631-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable